Targeting GLP-1, GIP, and glucagon receptors, retatrutide is a cutting-edge experimental peptide called a triple hormone receptor agonist. Belonging to the metabolic and weight control peptide class, this potent peptide provides a special action mechanism that might help with appetite control, fat loss, and better glucose metabolism.

Originally designed for studies on obesity and type 2 diabetes, Retatrutide has drawn interest for its possible impacts on weight loss, insulin sensitivity, and general metabolic health. It is a next-generation peptide with improved synergistic activity by blending the advantages of GLP-1, GIP, and glucagon signaling.